Plexiform neurofibromas (PNF) are benign, often infiltrative tumours of the peripheral nerve sheath classically linked to ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...

Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...

Komal Jhaveri - Breast Medical Oncologist and Early Drug Development Specialist, Memorial Sloan Kettering Cancer Center, New York, ...

After a finite number of divisions, cells simply give up. As each round of replication trims their telomeres-the protective ...

Researchers at Tulane University, with a team of colleagues from eight other universities, have discovered a new nerve cell ...

New research reveals that neurons release a little-understood extracellular kinase called VLK to strengthen synaptic connections, providing a missing piece in how the nervous system adapts during ...

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion ...

Scientists from Tulane University and The University of Texas at Dallas have discovered a new way that nerve cells communicate – by releasing an enzyme outside the cell that switches on pain signaling ...